In 2023, Japan's government expenditures on R&D health stood at $252.00 million USD PPP. The forecast indicates a significant downward trend from 2024 with expenditures declining steadily over the next five years, from $201.74 million to $10.63 million in 2028. This represents a drastic year-on-year percentage drop, with a compound annual growth rate (CAGR) of -37.45% over this period.

Future trends to watch for:

Possible reallocations in budgeting priorities affecting health R&D investments.
Impact of decreased funding on innovation and healthcare advancements.
Potential adjustments in policy to counteract negative outcomes from reduced investments.